Fredric L. Goldfein - Member

1880 John F. Kennedy Boulevard, 20th Floor
Philadelphia, PA 19103-7396
Telephone: 215.979.8200
Facsimile: 215.979.8201
Email: fgoldfein@goldfeinlaw.com

Rick Goldfein has over 25 years of national litigation experience in defending major casualty, toxic tort and professional liability claims. He has particular expertise in medical-legal matters on behalf of healthcare providers and their insurers, as well as drug and device manufacturers. Having successfully defended hundreds of cases at trial and on appeal, he is frequently consulted for expert strategic planning in complex and high profile cases.

Mr. Goldfein has lectured at numerous continuing legal education courses in Pennsylvania and New York. In addition, he has presented to physician groups on current issues in medical malpractice and at national seminars on asbestos and toxic torts. Current presentations include "Medical Malpractice and Risk Management - Lessons From a Litigator," "Litigation - Managing the Monster," and "Strategies for Giving Deposition and Trial Testimony."

Mr. Goldfein has been published in the Temple Law Review, Business Insurance, and Corporate Legal Times. For his successful defense of a First Amendment case involving a short-seller and a pharmaceutical company, he received national media coverage in Bloomberg and Barron's Technology Week, and locally in The Philadelphia Inquirer and The Legal Intelligencer. In recognition of his professional excellence, the publishers of Law & Politics named him to the list of "Pennsylvania Super Lawyers," 2004, 2005, 2006 and 2007, as featured in Philadelphia magazine, a distinction reserved for only 5% of Pennsylvania's attorneys, based upon a peer selection process.

Mr. Goldfein graduated from Villanova University School of Law and received his undergraduate degree from Columbia University. He is admitted to practice in Pennsylvania, New York and Maryland, as well as before the United States Supreme Court and the United States Court of Appeals for the Third Circuit.